Dynapenia Rather Than Sarcopenia Is Associated with Metabolic Syndrome in Patients with Chronic Liver Diseases.

chronic liver disease dynapenia metabolic syndrome sarcopenia

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
14 Jul 2021
Historique:
received: 04 06 2021
revised: 05 07 2021
accepted: 12 07 2021
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 8 8 2021
Statut: epublish

Résumé

We aimed to examine the association between sarcopenia-related factors and metabolic syndrome (Met-S) in patients with chronic liver diseases (CLDs, n = 582, average age = 59.5 years, 290 males, 168 liver cirrhosis cases). Met-S was determined based on the Japanese criteria. Sarcopenia was determined based on grip strength (GS) and skeletal muscle index (SMI) by bioelectrical impedance analysis. Our cohort was divided into the four groups: (A) sarcopenia (n = 44), (B) dynapenia (n = 45), (C) presarcopenia (n = 112), and (D) the control (n = 381). Impacts of GS and SMI on Met-S were investigated. In males, waist circumference (WC) ≥ 85 cm was observed in 199 patients (68.6%), while in females, WC ≥ 90 cm was observed in 94 patients (32.2%). Met-S was identified in 109 patients (18.7%). The proportion of Met-S in the group A, B, C and D were 18.2%, 48.9%, 8.0%, and 18.4% (A vs. B,

Identifiants

pubmed: 34359344
pii: diagnostics11071262
doi: 10.3390/diagnostics11071262
pmc: PMC8305206
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Hepatol Res. 2018 Oct;48(11):893-904
pubmed: 29734510
BMC Endocr Disord. 2019 Apr 25;19(1):40
pubmed: 31023282
Clin Liver Dis. 2015 May;19(2):223-38
pubmed: 25921660
Hepatol Res. 2020 Aug;50(8):892-923
pubmed: 32343469
J Am Med Dir Assoc. 2014 Feb;15(2):150.e11-6
pubmed: 24291347
Expert Rev Gastroenterol Hepatol. 2018 Dec;12(12):1229-1244
pubmed: 30791794
Curr Opin Clin Nutr Metab Care. 2019 May;22(3):185-190
pubmed: 30893090
Diabetol Metab Syndr. 2020 Jul 14;12:60
pubmed: 32684985
Obes Res Clin Pract. 2018 Jan - Feb;12(Suppl 2):1-8
pubmed: 27083404
Diagnostics (Basel). 2020 Apr 20;10(4):
pubmed: 32325995
Clin Nutr. 2004 Oct;23(5):1226-43
pubmed: 15380917
Nutrition. 2012 May;28(5):495-503
pubmed: 22469110
Aliment Pharmacol Ther. 2020 Jan;51(1):64-77
pubmed: 31701570
Cell Metab. 2019 Apr 2;29(4):844-855.e3
pubmed: 30595477
Hepatol Res. 2016 Sep;46(10):951-63
pubmed: 27481650
Curr Hypertens Rep. 2018 Feb 26;20(2):12
pubmed: 29480368
J Aging Health. 2012 Aug;24(5):812-26
pubmed: 22451528
Clin Cases Miner Bone Metab. 2015 Jan-Apr;12(1):22-6
pubmed: 26136791
J Diabetes Investig. 2019 Sep;10(5):1332-1340
pubmed: 30677242
J Nutr Health Aging. 2007 Mar-Apr;11(2):111-8
pubmed: 17435953
Epidemiol Health. 2017 Jan 6;39:e2017003
pubmed: 28092931
Hepatol Res. 2021 May 31;:
pubmed: 34057800
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):915-925
pubmed: 28627027
Clin Nutr. 2016 Feb;35(1):199-204
pubmed: 25736030
J Clin Med Res. 2018 Dec;10(12):920-927
pubmed: 30425765
Int J Mol Sci. 2020 Jul 24;21(15):
pubmed: 32722100
Nat Rev Endocrinol. 2018 Sep;14(9):513-537
pubmed: 30065268
Clin Nutr. 2019 Aug;38(4):1489-1495
pubmed: 30316536
Antioxidants (Basel). 2021 Feb 10;10(2):
pubmed: 33578702
J Clin Invest. 2019 Oct 1;129(10):4050-4057
pubmed: 31573550
Hepatol Res. 2020 Jul;50(7):791-816
pubmed: 32343477
Ann Surg Oncol. 2021 Jan;28(1):405-416
pubmed: 32965614
Lancet. 2015 Jul 18;386(9990):266-73
pubmed: 25982160
Scand J Med Sci Sports. 2018 Aug;28(8):1852-1858
pubmed: 29723933
Nutrients. 2018 Aug 12;10(8):
pubmed: 30103528
N Engl J Med. 1995 Nov 9;333(19):1260-6
pubmed: 7566004
J Gastroenterol. 2020 Mar;55(3):353-362
pubmed: 31768801
J Clin Invest. 2017 Jan 3;127(1):43-54
pubmed: 28045398
J Clin Gastroenterol. 2014 Feb;48(2):172-7
pubmed: 24402120
Lancet Diabetes Endocrinol. 2014 Nov;2(11):901-10
pubmed: 24731669
Clin Transplant. 2015 Mar;29(3):211-5
pubmed: 25594826
J Am Med Dir Assoc. 2017 Sep 1;18(9):807.e9-807.e16
pubmed: 28676289

Auteurs

Hiroki Nishikawa (H)

Department of Internal Medicine, Division of Gastroenterology and Hepatology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan.
The Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.

Kazunori Yoh (K)

Department of Internal Medicine, Division of Gastroenterology and Hepatology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan.

Hirayuki Enomoto (H)

Department of Internal Medicine, Division of Gastroenterology and Hepatology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan.

Shuhei Nishiguchi (S)

Kano General Hospital, Osaka 531-0041, Japan.

Hiroko Iijima (H)

Department of Internal Medicine, Division of Gastroenterology and Hepatology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan.

Classifications MeSH